Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives.
D050260:Carbohydrate Metabolism; D003276:Contraceptives, Oral / Q000008:administration & dosage; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D004717:Endometrium / Q000473:pathology; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008099:Liver / Q000502:physiology; D008599:Menstruation Disturbances / Q000139:chemically induced; D009644:Norgestrel / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D014592:Uterine Hemorrhage / Q000139:chemically induced
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D008055:Lipids; D009644:Norgestrel; D004997:Ethinyl Estradiol; D011374:Progesterone